Omada Health, Inc. Financing Cash Flow
Omada Health, Inc. (OMDA) reported Financing Cash Flow of $10.72 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-07
- Omada Health, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $7.60M, a 95.31% decline year-over-year.
- Omada Health, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $3.12M, a 738.71% increase year-over-year.
- Omada Health, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $3.38M, a 2887.61% increase year-over-year.
- Omada Health, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$32.66M.
- Omada Health, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $133.22M.
- Omada Health, Inc. net cash provided by (used in) financing activities for fiscal 2024 was -$1.21M, a 775.42% decline from fiscal 2023.
- Omada Health, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $179.00K.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $10.72M 10-Q · filed 2026-08-07 | $14.10M derived: sum of 3 quarters · filed 2026-08-07 | -$18.57M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $3.12M 10-Q · filed 2026-05-08 | $6.50M derived: sum of 2 quarters · filed 2026-05-08 | -$26.17M derived: sum of 3 quarters · filed 2026-05-08 | $135.97M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | -$29.29M derived: sum of 2 quarters · filed 2026-03-06 | $132.85M derived: sum of 3 quarters · filed 2026-08-07 | $133.22M 10-K · filed 2026-03-06 |
| 2025-09-30 | -$32.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $129.48M derived: sum of 2 quarters · filed 2026-08-07 | $129.85M 10-Q · filed 2025-11-07 | $129.96M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $162.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $162.51M 10-Q · filed 2026-08-07 | $162.63M derived: sum of 3 quarters · filed 2026-08-07 | $162.20M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $372.00K 10-Q · filed 2026-05-08 | $485.00K derived: sum of 2 quarters · filed 2026-05-08 | $61.00K derived: sum of 3 quarters · filed 2026-05-08 | |
| 2024-12-31 | $113.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | -$311.00K derived: sum of 2 quarters · filed 2026-03-06 | -$1.21M 10-K · filed 2026-03-06 | |
| 2024-09-30 | -$424.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$1.32M 10-Q · filed 2025-11-07 | ||
| 2024-06-30 | -$898.00K 10-Q · filed 2025-08-08 | |||
| 2023-12-31 | $179.00K 10-K · filed 2026-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |